Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice.
Nakamura N, Hara T, Shimizu M, Mabuchi R, Nagano J, Ohno T, Kochi T, Kubota M, Shirakami Y, Goto N, Ito H, Saito K, Tanaka T, Moriwaki H, Tsurumi H.
Nakamura N, et al. Among authors: nagano j.
Int J Hematol. 2015 Sep;102(3):327-34. doi: 10.1007/s12185-015-1835-8. Epub 2015 Aug 5.
Int J Hematol. 2015.
PMID: 26243621